Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer

被引：0
|
作者：
S Mitsunaga
M Ikeda
S Shimizu
I Ohno
J Furuse
M Inagaki
S Higashi
H Kato
K Terao
A Ochiai
机构：
[1] National Cancer Center Hospital East,Division of Hepatobiliary and Pancreatic Oncology
[2] Research Center for Innovative Oncology,Pathology Division
[3] National Cancer Center Hospital East,Department of Medical Oncology
[4] Kyorin University School of Medicine,Primary Lifecycle Management Department
[5] Center for Suicide Prevention,Clinical Research Planning Department
[6] National Institute of Mental Health,undefined
[7] National Center of Neurology and Psychiatry,undefined
[8] Chugai Pharmaceutical Co.,undefined
[9] Ltd.,undefined
[10] Chugai Pharmaceutical Co.,undefined
[11] Ltd.,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
pancreatic cancer; gemcitabine; interleukin-1; interleukin-6; chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2063 / 2069
页数：6
相关论文
共 50 条
  • [1] Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer
    Mitsunaga, S.
    Ikeda, M.
    Shimizu, S.
    Ohno, I.
    Furuse, J.
    Inagaki, M.
    Higashi, S.
    Kato, H.
    Terao, K.
    Ochiai, A.
    BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 2063 - 2069
  • [2] Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer
    Shen, Feifei
    Liu, Chuan
    Zhang, Weiguo
    He, Sijia
    Wang, Fan
    Wang, Jingjue
    Li, Qi
    Zhou, Fei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Use of elevated IL-1 to predict prognosis in patients with advanced pancreatic cancer with high IL-6 and wasting condition.
    Mitsunaga, S.
    Ikeda, M.
    Nakachi, K.
    Ohno, I.
    Shimizu, S.
    Takahashi, H.
    Okuyama, H.
    Inagaki, M.
    Furuse, J.
    Ochiai, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Correlation between IL-1β, IL-6 and HDL serum levels
    Pistamaltzian, N
    Regli, A
    Drosos, T
    Caroni, C
    Kosioni, E
    Ligoura, P
    Zografos, P
    Konstantinidis, I
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 33 - 34
  • [5] SERUM LEVELS OF IL-1, IL-6 AND IL-17 CHANGES IN HEART FAILURE PATIENTS
    Sun, Xiaojun
    Li, Chunli
    Qin, Hua
    Lu, Jing
    ACTA MEDICA MEDITERRANEA, 2019, 35 (05): : 2463 - 2467
  • [6] IL-6 serum levels predict postoperative morbidity in gastric cancer patients
    Antoni M. Szczepanik
    Lucyna Scislo
    Thecla Scully
    Elzbieta Walewska
    Maciej Siedlar
    Piotr Kolodziejczyk
    Marzena Lenart
    Magdalena Rutkowska
    Aleksander Galas
    Antoni Czupryna
    Jan Kulig
    Gastric Cancer, 2011, 14 : 266 - 273
  • [7] IL-6 serum levels predict postoperative morbidity in gastric cancer patients
    Szczepanik, Antoni M.
    Scislo, Lucyna
    Scully, Thecla
    Walewska, Elzbieta
    Siedlar, Maciej
    Kolodziejczyk, Piotr
    Lenart, Marzena
    Rutkowska, Magdalena
    Galas, Aleksander
    Czupryna, Antoni
    Kulig, Jan
    GASTRIC CANCER, 2011, 14 (03) : 266 - 273
  • [8] IL-1β, TNF-α, and IL-6 levels in gingival fluid and serum of patients with ischemic stroke
    Wytrykowska, Anna
    Prosba-Mackiewicz, Maria
    Nyka, Walenty M.
    JOURNAL OF ORAL SCIENCE, 2016, 58 (04) : 509 - 513
  • [9] Serum TNF-α, IL-1β, and IL-6 levels in chronic HBV-infected patients
    Bekcibasi, Muhammed
    Deveci, Ozcan
    Oguz, Abdullah
    Bozkurt, Fatma
    Dayan, Saim
    celen, Mustafa Kemal
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (08)
  • [10] Serum IL-1β, IL-2, IL-6, and IL-8 Levels in Schizophrenia Subtypes
    Kuloglu, Murat
    Bayik, Yilmaz
    Unal, Ahmet
    Gecici, Omer
    Ustundag, Bilal
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (03): : 193 - 200
12345